Skip to search formSkip to main content

TEMPI Syndrome

A rare syndrome characterized by telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Daratumumab in the TEMPI Syndrome Patients with the TEMPI syndrome often have a response to bortezomib or autologous… Expand
  • figure 1
Is this relevant?
Review
2018
Review
2018
TEMPI (telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections… Expand
  • table 1
  • table 2
Is this relevant?
2015
2015
BACKGROUND Collection of hematopoietic progenitor cells by apheresis (HPC-A) requires separation of cells by density. Previous… Expand
Is this relevant?
Review
2015
Review
2015
TEMPI syndrome (telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2015
2015
Long-term complete clinical and hematological responses of the TEMPI syndrome after autologous stem cell transplantation 
  • figure 1
  • table 1
  • table 1
Is this relevant?
2012
2012
We present an interesting case of a woman with new onset hypertension and abdominal fullness who was found to have huge bilateral… Expand
  • figure 1
  • figure 2
Is this relevant?
2012
2012
Additional cases are reported in which bortezomib reverses many of the manifestations of the TEMPI syndrome. 
  • figure 1
Is this relevant?
2012
2012
Telangiectasias, erythrocytosis, monoclonal gammopathy, perinephric-fluid collection, and intrapulmonary shunting are… Expand
  • figure 1
  • table 1
Is this relevant?
Review
2011
Review
2011
To the Editor: The description of a man with erythrocytosis and perinephric fluid collections recently appeared in the Case… Expand
  • figure 1
  • table 1
Is this relevant?